Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

May 9, 2025

Study Completion Date

July 30, 2025

Conditions
Abdominal Injury
Interventions
DRUG

Lumason

Lumason will be administered at a dose of 0.03 mL/kg up to a maximum dose of 2.4mL injected into a peripheral intravenous catheter. An abdominal contrast enhanced ultrasound will be performed to look for solid organ injury. The will be given twice during the intervention, for a total maximum dose per subject of 4.8mL.

Trial Locations (5)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

75390

University of Texas Southwestern Medical Center, Dallas

84113

University of Utah, Salt Lake City

85016

Phoenix Children's Hospital, Phoenix

02118

Boston Children's Hospital, Boston

All Listed Sponsors
lead

David Mooney

OTHER